Traditional digital healthcare solutions have revolved around episodic, often reactive, medical consultations and interventions. These models face challenges in continuous patient monitoring, real-time data analysis, and proactive health management.
With the advent of chronic diseases and aging populations, continuous, preventive healthcare has become paramount.
Wireless wearable health monitoring devices emerge as a revolutionary solution to these challenges. It offers continuous monitoring, real-time data analytics, and personalized health insights.
Unlike traditional healthcare devices, these wearables provide seamless, non-invasive, and user-friendly options for patients and healthcare providers. They enable early detection of potential health issues, facilitating timely medical interventions.
This article describes five startups developing innovative wireless wearable devices for health monitoring in 2024.
Interested in knowing how the healthcare industry is changing with digital technologies like data analytics, AI, and connectivity technologies, and what new trends are shaping it. Our exclusive report on digital healthcare covers this and more details about innovations, startups, and companies.
Fill out the form below to get your copy of this report delivered to your inbox:
1. Kardi AI
| Founding Year | 2022 |
| Headquarter | Olomoucky kraj, Czech Republic |
| Total Funding Amount | €1.9M |
| Last Funding Round/Amount | €1.5M/seed round |
| Website | kardi.ai |
Kardi AI is a Czech-based startup that offers telemedicine and patient healthcare tools. Its service enables long-term EKG monitoring for preventive heart health care, early arrhythmia detection, and treatment optimization using artificial intelligence.
Founded in 2022, the startup aims to introduce an affordable diagnostic solution to the market, providing patients with a tool for heart healthcare that reduces the necessity for frequent doctor visits.
The Kardi AI service connects an EKG recording device with a unique application. The application monitors your heart rhythm and immediately alerts you in case of irregularities. It also generates a detailed report about your cardiac activity for your doctor.
It was founded by doctor Tomáš Skála, serial entrepreneur Stephen Burke, technologist Pavel Digaňa, and product designer David Skala.
Kardi AI has raised €1.9M in funding over two rounds. Their latest funding was from a seed round on November 28, 2023.
Related Read
2. Pulsetto
| Founding Year | 2022 |
| Headquarter | Vilnius, Vilniaus Apskritis, Lithuania |
| Total Funding Amount | €550K |
| Last Funding Round/Amount | €500K, pre-seed round |
| Website | pulsetto.tech |
Pulsetto has developed a device for stress relief and better sleep. The device stimulates the vagus nerve in the parasympathetic nervous system, which controls the heart, lungs, and digestive system. Stimulating the nerve slows down the heart rate and encourages relaxation.
Their device uses electromagnetic waves to easily and safely activate the vagus nerve. Vagus nerve stimulation has been used in medicine since 1988, but previously, it was an invasive procedure. Pulsetto’s solution allows them to provide the benefits without entering the operating room.
Vitalijus Majorovas, the company’s CEO and Co-founder, is a certified sleep and recovery coach. He recognized the potential of Vagus Nerve Stimulation (VNS) and created an effective and comfortable device for everyday use.
Pulsetto has raised €550K in funding over two rounds. Their latest funding was from a pre-seed round on April 28, 2022.
Related Read
3. Strados Labs
| Founding Year | 2016 |
| Headquarter | Philadelphia, Pennsylvania, United States |
| Total Funding Amount | $8.2 million |
| Last Funding Round/Amount | Venture Round/$585K |
| Website | stradoslabs.com |
Strados Labs is a medical technology company that develops smart sensor platforms using machine learning and proprietary algorithms. Their main product is the RESP Biosensor, a wearable device that can remotely and continuously capture lung sounds and events like cough and wheezing.
The RESP Biosensor is designed to help manage lung health from hospital to home. This technology is particularly useful for managing diseases such as COPD or Asthma. Furthermore, this has been used in clinical trials across three continents and seven languages.
The startup aims to improve the quality of life for patients with chronic respiratory diseases by providing a stronger understanding of treatment response and earlier insight into exacerbations to prevent unnecessary hospitalizations.
Strados Labs was founded by Nick Delmonico. He has a diverse professional background spanning both healthcare and finance. It has raised $8.2M in funding over eight rounds.
Related Read
4. Oxitone Medical
| Founding Year | 2010 |
| Headquarter | Kfar Saba, HaMerkaz, Israel |
| Total Funding Amount | $10.5M |
| Last Funding Round/Amount | Convertible Note/$1 million |
| Website | oxitone.com/oxitone-1000m |
Oxitone Medical is a wearables and digital health startup that provides continuous remote care for people with severe chronic and complex conditions.
Their main product is the Oxitone 1000M, a wrist-sensor pulse oximetry monitor. This device measures physiological parameters such as respiratory rate, skin temperature, sleep patterns, blood oxygen (SpO₂), pulse rate, and fall detection.
The Oxitone 1000M works without a bulky fingertip probe. The device is connected to Oxitone’s proprietary cloud software platform, which generates continuous remote measurements of multiple physiological parameters. It helps to flag any critical deviations in a timely manner.
Founded by serial entrepreneurs Leon Eisen and Ofer Harpak, Oxitone Medical has raised $10.5M in funding over five rounds.
Related Read
5. Mira
| Founding Year | 2015 |
| Headquarter | Pleasanton, California, United States |
| Total Funding Amount | $4.3 million |
| Last Funding Round/Amount | $2.2 million via a venture round |
| Website | miracare.com |
Mira is a fertility system that provides personalized cycle prediction by measuring fertility hormone concentrations and AI algorithms. Their Mira Monitor is an advanced in-home monitor designed to show the full fertile window by tracking actual hormone levels.
This system helps predict ovulation accurately, identify a full 6-day fertile window, confirm ovulation during a specific cycle, and determine if the person is fertile. It provides insights with lab-grade accuracy into how the user’s body works and helps to make decisions without a doctor’s visit.
Sylvia M. Kang is the CEO and Co-founder of Mira. She holds an MBA from Cornell University. The startup has raised $4.3M in funding over three rounds.
Partner with these cutting-edge startups to tackle your industry’s toughest challenges and stay on top of the competition.
Learn how GreyB helps you discover similar ventures that perfectly fit your needs.
How Can We Help You?
We support industry-leading R&D and Innovation professionals through complex problems. Describe your challenge, and let us bring clarity and expertise.
Read Next
